Nucleos(t)ide analog therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nucleos(t)ide analog therapy, covering 2025-06-25 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment [EARLY_Phase 1]